Literature DB >> 29567752

Consensus on MRD in AML?

Elisabeth Paietta1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29567752     DOI： 10.1182/blood-2018-01-828145

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

Review 1.  When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter.

Authors:  Gregory W Roloff; Elizabeth A Griffiths
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter.

Authors:  Gregory W Roloff; Elizabeth A Griffiths
Journal:  Blood Adv       Date:  2018-11-13

Review 3.  Minimal/Measurable Residual Disease Detection in Acute Leukemias by Multiparameter Flow Cytometry.

Authors:  Franklin Fuda; Weina Chen
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

Review 4.  Dendritic Cells of Leukemic Origin: Specialized Antigen-Presenting Cells as Potential Treatment Tools for Patients with Myeloid Leukemia.

Authors:  Daniel Christoph Amberger; Helga Maria Schmetzer
Journal:  Transfus Med Hemother       Date:  2020-11-05       Impact factor: 3.747

5.  Inhibiting autophagy targets human leukemic stem cells and hypoxic AML blasts by disrupting mitochondrial homeostasis.

Authors:  Kaitlyn M Dykstra; Hannah R S Fay; Ashish C Massey; Neng Yang; Matthew Johnson; Scott Portwood; Monica L Guzman; Eunice S Wang
Journal:  Blood Adv       Date:  2021-04-27

6.  Clustering and Kernel Density Estimation for Assessment of Measurable Residual Disease by Flow Cytometry.

Authors:  Hugues Jacqmin; Bernard Chatelain; Quentin Louveaux; Philippe Jacqmin; Jean-Michel Dogné; Carlos Graux; François Mullier
Journal:  Diagnostics (Basel)       Date:  2020-05-18

Review 7.  MRD in AML: The Role of New Techniques.

Authors:  Maria Teresa Voso; Tiziana Ottone; Serena Lavorgna; Adriano Venditti; Luca Maurillo; Francesco Lo-Coco; Francesco Buccisano
Journal:  Front Oncol       Date:  2019-07-23       Impact factor: 6.244

Review 8.  Flow-Cytometric Monitoring of Minimal Residual Disease in Pediatric Patients With Acute Myeloid Leukemia: Recent Advances and Future Strategies.

Authors:  Barbara Buldini; Margarita Maurer-Granofszky; Elena Varotto; Michael N Dworzak
Journal:  Front Pediatr       Date:  2019-10-11       Impact factor: 3.418

Review 9.  MRD Monitoring by Multiparametric Flow Cytometry in AML: Is It Time to Incorporate Immune Parameters?

Authors:  Ilias Pessach; Theodoros Spyropoulos; Eleftheria Lamprianidou; Ioannis Kotsianidis
Journal:  Cancers (Basel)       Date:  2022-09-01       Impact factor: 6.575
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.